Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Goodwill (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Goodwill for 9 consecutive years, with $431000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Goodwill changed 0.0% to $431000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $431000.0, a 0.0% change, with the full-year FY2025 number at $431000.0, changed 0.0% from a year prior.
  • Goodwill was $431000.0 for Q4 2025 at Ekso Bionics Holdings, roughly flat from $431000.0 in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $431000.0 in Q4 2022 to a low of $431000.0 in Q4 2022.
  • A 4-year average of $431000.0 and a median of $431000.0 in 2022 define the central range for Goodwill.
  • Biggest YoY gain for Goodwill was 0.0% in 2023; the steepest drop was 0.0% in 2023.
  • Ekso Bionics Holdings' Goodwill stood at $431000.0 in 2022, then changed by 0.0% to $431000.0 in 2023, then changed by 0.0% to $431000.0 in 2024, then changed by 0.0% to $431000.0 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Goodwill are $431000.0 (Q4 2025), $431000.0 (Q3 2025), and $431000.0 (Q2 2025).